The FDA has proposed changes to its requirements for medical device clinical trials conducted outside the U.S., including mandating that manufacturers provide documentation on human subjects' informed consent as well as on trial evaluation and approval by an independent ethics panel. The proposal is up for comment through May 28.
FDA plan would revise rules on device trials outside U.S.
SmartBrief Job Listings for Health Care
|Account Manager, Group Health Insurance||
|Los Angeles, CA|
|Senior Counsel - Research and Development - 14000000WQ||
|Chief Medical Officer||
|Vice President, Public Policy and Communications||
National Committee for Quality Assurance
|Counsel II – Corporate Legal Affairs||
|Foster City, CA|